投资者关系活动记录表 证券代码：688323 证券简称：瑞华泰 转债代码：118018 转债简称：瑞科转债 深圳瑞华泰薄膜科技股份有限公司 机构投资者调研活动记录表 编号：2023-007  特定对象调研 口分析师会议 口媒体采访 口业绩说明会 投资者活动 类别 口新闻发布会 口路演活动  现场参观  其他（线上会议） 参与单位 华福证券、华创证券、润达基金、博时基金、善思投资、创富兆业 名称 时间 2023年11月16日 地点 深圳瑞华泰 上市公司接待 柳南舟、张政、周绵雪 人姓名 一、嘉兴募投项目进展情况？ 4条设计产能200吨的主生产线和各工厂系统安装工作已完成，并进行 了设备调试，第三季度进行了投料产品调试，后续将加快生产线的工艺稳定 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-045 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于部分董事持股方式拟由间接持有变更为直接持 有的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本次变动系公司董事俞峰先生持有公司股份的方式将由间接持有变更为 直接持有，不构成增持或减持股份的行为，不触及要约收购。 本次变动不会导致公司控股股东及实际控制人发生变化。 近日，深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"或"瑞华泰" ）接到公司股东上海联升创业投资有限公司（以下简称"联升创业"）、上海联升 承业创业投资有限公司（以下简称"联升承业"）及相关人员的通知，联升创业 及联升承业拟根据市场情况通过盘后固定价格交易将27,631股公司股份（股份性 质为无限售条件流通股，占公司总股本的0.02%）转让给公司董事俞峰先生。俞 峰先生因间接持有联升创业及联升承业的财产份额，从而间 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-044 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于不向下修正"瑞科转债"转股价格的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 截至 2023 年 11 月 3 日，深圳瑞华泰薄膜科技股份有限公司（以下简称 "公司"）股价已触发"瑞科转债"转股价格向下修正条款。 经公司第二届董事会第十六次会议审议，公司董事会决定本次不向下修 正"瑞科转债"转股价格，同时在未来六个月内（即自本公告披露日至 2024 年 5 月 3 日），如再次触发"瑞科转债"转股价格向下修正条款，亦不提出向下修 正方案。 一、可转换公司债券基本情况 经中国证券监督管理委员会《关于同意深圳瑞华泰薄膜科技股份有限公司向 不特定对象发行可转换公司债券注册的批复》（证监许可〔2022〕1546 号）同意 注册，公司于 2022 年 8 月 18 日向不特定对象共计发行 4 ...

投资者关系活动记录表 证券代码：688323 证券简称：瑞华泰 转债代码：118018 转债简称：瑞科转债 深圳瑞华泰薄膜科技股份有限公司 机构投资者调研活动记录表 编号：2023-006 特定对象调研 口分析师会议 口媒体采访 口业绩说明会 投资者活动 类别 口新闻发布会 口路演活动 现场参观  其他（线上会议） 国海证券、山西证券、中信证券、国金证券、申万宏源、万和证券、中银证 券、民生证券、甬兴证券、宝盈基金、易方达基金、南方基金、鹏华基金、 恒越基金、嘉实基金、天弘基金、长城基金、中金基金、惠升基金、淳厚基 金、华商基金、华宝信托、长安国际信托、汇安基金、枫瑞基金、新华基金、 汇添富基金、永赢基金、富荣基金、景顺长城基金、益民基金、富安达基金、 方正富邦基金、明世伙伴基金、泰达宏利基金、上海涌乐投资基金、中信保 参与单位 名称 诚、久久投资、远策投资、拾贝投资、昭图投资、上海泊通投资、江苏瑞华 投资、上海度势投资、上海仙人掌私募、广州趋势私募、厦门财富管理、大 家资产、万和资管、深圳大道至诚资管、杭州乾璐资管、上海重阳资管、上 ...

Financial Performance - The company's operating revenue for Q3 2023 was ¥86,515,440.35, representing a year-on-year increase of 41.19% and a quarter-on-quarter increase of 11.91%[5]. - The net profit attributable to shareholders for Q3 2023 was ¥259,922.45, a significant decrease of 96.87% compared to the same period last year[5]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for Q3 2023 was -¥1,091,656.32, down 144.16% year-on-year[5]. - Total revenue for the first three quarters of 2023 was CNY 208,531,729.94, a decrease of 6.4% compared to CNY 223,425,717.85 in the same period of 2022[21]. - Operating profit for the third quarter was a loss of CNY 9,630,269.10, compared to a profit of CNY 37,871,100.25 in the previous year[22]. - Net profit for the third quarter was a loss of CNY 7,672,737.17, down from a profit of CNY 35,368,964.98 in the same quarter of 2022[23]. - Basic earnings per share for the third quarter was -CNY 0.04, compared to CNY 0.20 in the previous year[24]. Assets and Liabilities - Total assets at the end of Q3 2023 were ¥2,442,119,874.08, reflecting a 5.42% increase from the end of the previous year[6]. - Non-current assets totaled CNY 2,067,269,195.03, an increase from CNY 1,833,677,224.18 year-over-year[20]. - Total liabilities increased to CNY 1,430,826,281.41, up from CNY 1,285,043,936.58 in the previous year[20]. - As of September 30, 2023, the company's total current assets decreased to ¥374,850,679.05 from ¥482,929,354.12 at the end of 2022, representing a decline of approximately 22.4%[18]. - The company's cash and cash equivalents dropped significantly to ¥129,475,362.23 from ¥270,746,346.38, indicating a decrease of about 52.2%[18]. Cash Flow - In the first three quarters of 2023, the cash inflow from operating activities was CNY 195,267,439.89, a decrease of 13.3% compared to CNY 225,244,813.76 in the same period of 2022[25]. - The net cash outflow from investing activities was CNY -207,035,354.20, significantly lower than CNY -362,742,329.46 in the previous year, indicating a reduction in investment expenditures[27]. - The net cash inflow from financing activities decreased to CNY 7,179,931.59 from CNY 525,730,004.22 in the same period last year, reflecting a substantial decline in financing activities[28]. - The total cash and cash equivalents at the end of Q3 2023 were CNY 128,551,767.20, down from CNY 431,404,997.79 at the end of Q3 2022, indicating a liquidity contraction[28]. - The cash flow from operating activities net amount was CNY 58,745,864.53, down 27.5% from CNY 81,022,658.26 in the same quarter of the previous year[27]. Research and Development - Research and development expenses totaled ¥7,998,640.33 in Q3 2023, accounting for 9.25% of operating revenue, a decrease of 1.61 percentage points year-on-year[6]. - Research and development expenses for the third quarter were CNY 24,087,450.86, an increase from CNY 20,027,901.99 in the same quarter of 2022[22]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,377[13]. - The top shareholder,航科新世纪科技发展(深圳)有限公司, holds 23.38% of the shares, totaling 42,083,059 shares[13]. Market and Operational Risks - The company is facing potential market risks, new product development risks, operational risks, and revenue shortfall risks associated with its new projects[16]. - The company is advancing its high-performance polyimide film project, with two production lines already in operation since September 2023, contributing to an expected additional capacity of 1,600 tons upon full completion[16]. - The company plans to accelerate market expansion in sectors such as new energy, flexible electronics, and high-speed communications, leveraging new products like COF PI and high thermal conductivity PI[16].

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-042 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 关于召开 2023 年第三季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2023 年 11 月 2 日(星期四)下午 14:00-15:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （http://roadshow.sseinfo.com/） 会议召开方式：网络文字互动 投资者可于 2023 年 10 月 26 日(星期四)至 11 月 1 日(星期三)16:00 前 登录上证路演中心网站首页点击"提问预征集"栏目或通过公司邮箱 ir@rayitek.cn 进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"）拟于 2023 年 10 月 30 日在上海证券交易 ...

| 证券代码：688323 证券简称：瑞华泰 | 公告编号：2023-041 | | --- | --- | | 转债代码：118018 转债简称：瑞科转债 | | 深圳瑞华泰薄膜科技股份有限公司 可转债转股结果暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 本季度转股情况：深圳瑞华泰薄膜科技股份有限公司（以下简称"公司"） 向不特定对象发行可转换公司债券"瑞科转债"自 2023 年 2 月 24 日起可转换为 公司股份，自 2023 年 7 月 1 日至 2023 年 9 月 30 日期间，"瑞科转债"共有人民 币 2,000 元已转换为公司股票，转股数量为 64 股，占"瑞科转债"转股前公司 已发行股份总额的 0.000036%。 累计转股情况：截至 2023 年 9 月 30 日，"瑞科转债"累计共有人民币 5,000 元已转换为公司股票，累计转股数量为 160 股，占"瑞科转债"转股前公 司已发行股份总额的 0.000089%。 未转股可转债情况：截至 2023 年 9 月 30 日 ...

| 证券代码：688323 | 证券简称：瑞华泰 | 公告编号：2023-040 | | --- | --- | --- | | 转债代码：118018 | 转债简称：瑞科转债 | | 重要内容提示： 线 上 文 字 互 动 平 台 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （http://roadshow.sseinfo.com/） 投资者可于 2023 年 9 月 7 日(星期四)16:00 前通过邮件、电话等形式将 需要了解和关注的问题提前提供给公司。公司将在文字互动环节对投资者普遍关 注的问题进行回答。 1 会议线上交流时间：2023 年 9 月 8 日(星期五) 下午 13:00-15:00 会议召开方式：线上文字互动 本次业绩说明会以线上文字互动形式召开，公司将针对 2023 年半年度的经 营成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的 范围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 深圳瑞华泰薄膜科技股份有限公司 关于参加 2023 年半年度新能源及新材料行业集体 业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载 ...

Financial Performance - The company reported a significant increase in revenue for the first half of 2023, achieving a total of RMB 500 million, representing a growth of 25% compared to the same period last year[14]. - The company's operating revenue for the first half of 2023 was ¥122,016,289.59, a decrease of 24.75% compared to ¥162,151,865.51 in the same period last year[22]. - The net profit attributable to shareholders for the first half of 2023 was -¥7,932,659.62, representing a decline of 129.32% from ¥27,055,711.33 in the previous year[22]. - The net cash flow from operating activities decreased by 26.99%, amounting to ¥38,769,846.78 compared to ¥53,099,203.46 in the same period last year[22]. - The gross profit margin for the first half of 2023 was reported at 35%, a slight increase from 32% in the previous year[14]. - The basic earnings per share for the first half of 2023 was -¥0.04, a decrease of 126.67% from ¥0.15 in the same period last year[24]. - The weighted average return on equity decreased by 3.82 percentage points to -0.78% compared to 3.04% in the previous year[24]. - The company reported a significant decrease in accounts receivable, with a 37.67% drop in notes receivable compared to the previous year[97]. - The company’s financial expenses increased due to the issuance of convertible bonds in August 2022, impacting net profit negatively[24]. Research and Development - The company has invested RMB 50 million in R&D for new technologies aimed at improving product efficiency and sustainability[14]. - Research and development expenses accounted for 13.19% of operating revenue, an increase of 4.94 percentage points compared to 8.25% in the same period last year[23]. - The company achieved a total R&D investment of ¥16,088,810.53, representing a 20.32% increase compared to ¥13,372,157.54 in the same period last year[59]. - The company obtained 3 new invention patents during the reporting period, bringing the total number of patents to 29, including 23 invention patents[56]. - The company has developed multiple series of high-performance polyimide (PI) films, becoming one of the suppliers with the most diverse product offerings in the industry[54]. - The company has accumulated significant laboratory research data, which helps shorten the new product development cycle[54]. - The company has focused on environmentally friendly production by replacing DMF solvent with DMAc solvent in its chemical process[55]. - The company is expanding its research into flexible perovskite solar cells, aiming to commercialize the technology for larger devices[62]. Market Strategy and Expansion - The company has provided a positive outlook for the second half of 2023, projecting a revenue growth of 20% to 30% based on current market trends and demand[14]. - The company is expanding its market presence in Southeast Asia, targeting a 10% market share by the end of 2024[14]. - A strategic acquisition of a local competitor is in progress, which is anticipated to increase production capacity by 40%[14]. - The company plans to enhance its supply chain management to reduce costs by 5% in the upcoming quarters[14]. - The company operates a production model combining sales-driven production and demand forecasting, primarily using direct sales complemented by agents[37]. Product Development - New product development includes the launch of a next-generation flexible film, expected to enhance market competitiveness and drive sales growth[14]. - The company specializes in the research, production, and sales of high-performance PI films, with major products including thermal control PI films, electronic PI films, and electrical PI films, filling domestic gaps and gaining recognition from renowned enterprises such as Siemens and Bombardier[29]. - The thermal control PI film is primarily used as a precursor for high thermal conductivity graphite films, suitable for consumer electronics, with key characteristics including high in-plane orientation and ease of graphitization[31]. - The electronic PI films are used in flexible printed circuits (FPC) for consumer electronics and 5G communication, achieving ultra-thin specifications of 5 microns and 7.5 microns, with 3-micron products already in small-scale applications[32]. - The electrical PI films serve as insulation materials for high-power motors and transformers, with the company’s corona-resistant PI films having passed certifications from major global players since 2014, breaking DuPont's long-standing global monopoly in this field[34]. - The aerospace PI films maintain performance stability in extreme environments and are currently supplied to the China Academy of Launch Vehicle Technology for use in domestic launch vehicles, filling a domestic gap[35]. - The company has developed a flexible display CPI film with excellent optical and mechanical properties, capable of over 200,000 folding cycles, and is in the process of optimizing production lines for flexible OLED applications[36]. Environmental and Compliance - The company has established an environmental protection mechanism and invested 1.83 million yuan in environmental protection during the reporting period[116]. - The company has implemented strict waste management and pollution control measures, including the recycling of solvents used in the production process[118]. - The company has conducted regular monitoring of waste gas emissions to ensure compliance with environmental standards[119]. - The company has no production wastewater discharge, utilizing a closed-loop system for process water and treating domestic wastewater before discharge[126]. - The company actively engages in carbon reduction measures, including the use of advanced production technology and energy-efficient equipment[127]. - The company has established a greenhouse gas management team to oversee carbon emissions and compliance with local regulations[127]. Shareholder and Governance - The company operates without a controlling shareholder, which may lead to decision-making challenges due to the relatively equal distribution of shareholding among major shareholders[90]. - The company emphasizes talent development, focusing on building a stable team of technical and management personnel to enhance operational capabilities[82]. - The company has committed to a share lock-up period of 36 months from the date of stock listing, during which shareholders cannot transfer or manage their shares[130]. - The company has established a long-term commitment to maintain compliance with regulatory changes regarding shareholding and transfer[133]. - The company will ensure that any new directors and senior management comply with the commitments made during the IPO process[139]. - The company has committed to ensuring the authenticity, accuracy, and completeness of the prospectus and other issuance application documents, bearing individual and joint legal responsibility for any false records or misleading statements[146]. Debt and Financial Management - As of June 30, 2023, the company had short-term borrowings of RMB 25 million and long-term borrowings of RMB 799.45 million, indicating significant debt levels[87]. - The company issued 4.3 million convertible bonds with a total amount of RMB 430 million, net proceeds after expenses were RMB 422.58 million[79]. - The total amount of guarantees provided by the company (including subsidiaries) is 571,895,058.97 RMB, which accounts for 56.57% of the company's net assets[159]. - The cumulative investment of raised funds as of the reporting period is 219,842,148.62 RMB, achieving an investment progress of 100.70% against the adjusted total commitment of 218,319,056.61 RMB[162]. - The company has not provided any guarantees to shareholders, actual controllers, or their related parties, with the amount being 0 RMB[159].

国信证券股份有限公司 关于深圳瑞华泰薄膜科技股份有限公司 使用部分暂时闲置募集资金进行现金管理的核查意见 国信证券股份有限公司（以下简称"国信证券"或"保荐机构"）作为深圳 瑞华泰薄膜科技股份有限公司（以下简称"瑞华泰"或"公司"）2021 年首次公 开发行股票并在科创板上市和 2022 年向不特定对象发行可转换公司债券的保荐 机构，根据《证券发行上市保荐业务管理办法》《上海证券交易所科创板股票上 市规则》、《科创板上市公司持续监管办法（试行）》、《上海证券交易所科创板上 市公司自律监管指引第 1 号——规范运作》及《上市公司监管指引第 2 号—— 上市公司募集资金管理和使用的监管要求》等法律法规的有关规定，对公司使用 部分暂时闲置募集资金进行现金管理的情况进行了核查，现将核查情况及核查意 见发表如下： 一、募集资金基本情况 根据中国证券监督管理委员会出具的《关于同意深圳瑞华泰薄膜科技股份有 限公司向不特定对象发行可转换公司债券注册的批复》（证监许可〔2022〕1546 号），公司向不特定对象发行可转换公司债券 430 万张，每张面值为人民币 100 元，按面值发行。本次发行合计募集资金人民币 43,000. ...